Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$691,508
-$65,154 QoQ
Shares Held
9,623
+50.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#724
of 1,408 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Sep 30, 2023CallValue
$0
CallShares
0
PutValue
$22,617,400
PutShares
130,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $126,095,704 across 18 Drug Manufacturers - Specialty & Generic names. ZTS ranks #16 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
277,821 | $30,821,461 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
309,682 | $19,804,163 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
702,858 | $17,227,049 | |
| 4 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
684,974 | $12,302,133 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
511,336 | $8,196,716 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
218,958 | $7,591,273 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
434,132 | $7,514,824 | |
| 8 | ALKS |
Alkermes plc.
|
142,366 | $7,459,978 |
All Filings in ZTS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $691,508 | 9,623 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $756,662 | 6,401 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $842,364 | 6,695 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $566,254 | 3,631 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $811,217 | 4,152 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $564,806 | 3,258 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,520,044 | 14,893 | Shares | Sole | 2024-05-13 | |
| 2023-09-30 | $1,091,376 | 6,273 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $22,617,400 | 130,000 | Put | Sole | 2023-11-14 | |
| 2023-06-30 | $935,616 | 5,433 | Shares | Other | 2023-08-14 | |
| 2023-06-30 | $11,193,650 | 65,000 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $3,403,530 | 20,449 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $3,491,259 | 23,823 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $20,367,779 | 137,351 | Shares | Other | 2022-11-15 | |
| 2022-06-30 | $59,447,468 | 345,846 | Shares | Other | 2022-08-15 | |
| 2021-12-31 | $2,920,795 | 11,969 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,529,434 | 7,878 | Shares | Sole | 2021-12-01 | |
| 2021-06-30 | $857,256 | 4,600 | Put | Sole | 2021-08-16 | |
| 2021-06-30 | $764,076 | 4,100 | Call | Sole | 2021-08-16 | |
| 2021-03-31 | $112,597,097 | 714,993 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,818,698 | 29,116 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||